Regulation of human T lymphoblast growth by sensory neuropeptides: augmentation of cholecystokinin-induced inhibition of Molt-4 proliferation by somatostatin and vasoactive intestinal peptide in vitro.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Immunology Letters

• Publication date

  1992-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0165-2478(92)90219-EPMID 1283156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• cDNA sequence and heterologous expression of the human neurokinin-3 receptor.

  1992cited by this paper
• Human lymphocytes lack substance P receptors.

  1992cited by this paper
• Priming of normal human neutrophils by tachykinins: tuftsin-like inhibition of in vitro chemotaxis stimulated by formylpeptide or interleukin-8.

  1991cited by this paper
• Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen.

  1991cited by this paper
• The inhibition effect of cholecystokinin in human colonic lamina propria lymphocyte proliferation, and reversal by the cholecystokinin receptor antagonist L-364718.

  1991cited by this paper
• Molecular cloning, structural characterization and functional expression of the human substance P receptor.

  1991cited by this paper
• Dual effect of vasoactive intestinal peptide on the mitogenic response of rabbit spleen lymphocytes.

  1990cited by this paper
• Gastrointestinal neuropeptides suppress human colonic lamina propria lymphocyte DNA synthesis.

  1990cited by this paper
• Molecular characterization of a functional cDNA encoding the rat substance P receptor.

  1990cited by this paper
• Receptors for substance P and related neurokinins.

  1989cited by this paper
• Cholecystokinin and the immune system: receptor-mediated chemotaxis of human and rat monocytes.

  1988cited by this paper
• Vasoactive intestinal peptide receptors in rat spleen and brain: a shared communication network.

  1988cited by this paper
• Potentiation of IL-1-induced BALB/3T3 fibroblast proliferation by neuropeptides.

  1988cited by this paper
• Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease.

  1988cited by this paper
• New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization.

  1988cited by this paper
• Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides.

  1988cited by this paper
• Neuropeptides and the Immune System: Substance P Receptors in Bronchus‐Associated Lymphoid Tissue of Rat

  1987cited by this paper
• Neuropeptides and immunity.

  1987cited by this paper
• Substrate specificity of a hypothalamic neurosecretory granule enzyme capable of processing pro-gonadotropin releasing hormone precursor protein.

  1987cited by this paper
• The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression.

  1987cited by this paper
• Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine.

  1987cited by this paper
• Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.

  1986cited by this paper
• Multiple tachykinin binding sites in peripheral tissues and in brain.

  1986cited by this paper
• Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen.

  1986cited by this paper
• Substance P receptors in rat spleen: characterization and autoradiographic distribution.

  1986cited by this paper
• Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for substance P.

  1986cited by this paper
• Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).

  1985cited by this paper
• Coexistence of peptide immunoreactivity in sensory neurons of the cat.

  1985cited by this paper
• Multiple tachykinins (neurokinin A, neuropeptide K and substance P) in capsaicin-sensitive sensory neurons in the guinea-pig.

  1985cited by this paper
• Cholecystokinin receptors: biochemical demonstration and autoradiographical localization in rat brain and pancreas using [3H] cholecystokinin8 as radioligand

  1984cited by this paper
• Themes and contrasts in protein structures

  1984cited by this paper
• Substance P recognition by a subset of human T lymphocytes.

  1984cited by this paper
• Stereospecific receptors for substance P on cultured human IM-9 lymphoblasts.

  1984cited by this paper
• Coexistence of cholecystokinin- and substance P-like peptides in neurons of the dorsal root ganglia of the rat.

  1982cited by this paper
• Identification of Human Mononuclear Leukocytes Bearing Receptors for Somatostatin and Glucagon

  1981cited by this paper

• “Every cell is an immune cell; contributions of non-hematopoietic cells to anti-helminth immunity”

  2022cites this paper
• Enteroendocrine cells-sensory sentinels of the intestinal environment and orchestrators of mucosal immunity

  2017cites this paper
• The intestinal immunoendocrine axis: novel cross-talk between enteroendocrine cells and the immune system during infection and inflammatory disease

  2015cites this paper
• Somatostatin in in ̄ ammatory bowel disease

  2014cites this paper
• and Substance P in Distinct Compartments of Human Lymphoid Organs Localization of Receptors for Vasoactive Intestinal Peptide, Somatostatin,

  2009cites this paper
• Expression of thymosin α1-thymopentin fusion peptide in Pichia pastoris and its characterization

  2008cites this paper
• Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets.

  2004cites this paper
• Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice

  2004cites this paper
• Expression and Function of Somatostatin and its Receptors in Immune Cells

  2004cites this paper
• Anti-inflammatory effect of cholecystokinin and its signal transduction mechanism in endotoxic shock rat.

  2002cites this paper
• Effect of cholecystokinin on cytokines during endotoxic shock in rats.

  2001cites this paper
• Differential Expression of Vasoactive Intestinal Polypeptide Receptor 1 and 2 mRNA in Murine Intestinal T Lymphocyte Subtypes

  2001cites this paper
• Differential role of neurokinin receptors in human lymphocyte and monocyte chemotaxis.

  2000cites this paper
• Immunology of VIP: a review and therapeutical perspectives.

  2000cites this paper
• Local Neurochemicals and Site‐Specific Immune Regulation in the CNS

  2000cites this paper
• Site-specific control of T cell traffic in the brain: T cell entry to brainstem vs. hippocampus after local injection of IFN-gamma.

  1999cites this paper
• Site‐specific immune regulation in the brain: Differential modulation of major histocompatibility complex (MHC) proteins in brainstem vs. hippocampus

  1999cites this paper
• Age-related changes in the modulatory action of gastrin-releasing peptide, neuropeptide Y and sulfated cholecystokinin octapeptide in the proliferation of murine lymphocytes.

  1999cites this paper
• Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs.

  1998influential citation
• Physiological roles of placental proteases in feto-placental homeostasis.

  1998cites this paper
• Peptide-amidating Enzymes Are Expressed in the Stellate Epithelial Cells of the Thymic Medulla

  1998cites this paper
• Changes with ageing in the modulation of murine lymphocyte chemotaxis by CCK-8S, GRP and NPY.

  1998cites this paper
• Modulation of murine lymphocyte functions by sulfated cholecystokinin octapeptide.

  1998cites this paper
• Dopamine and the regulation of cell proliferation in gerbil (Meriones unguiculatus) pyloric mucosa.

  1997cites this paper
• Inhibition of human neutrophil functions by sulfated and nonsulfated cholecystokinin octapeptides.

  1997cites this paper
• Somatostatin in inflammatory bowel disease

  1997cites this paper
• Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells.

  1997cites this paper
• Effect of cholecystokinin and gastrin on human peripheral blood lymphocyte functions, implication of cyclic AMP and interleukin 2.

  1997cites this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis.

  1996cites this paper
• Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA.

  1996cites this paper
• VIP modulation of immune cell functions.

  1996cites this paper
• The significance of vasoactive intestinal polypeptide (VIP) in immunomodulation.

  1996cites this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.

  1996cites this paper
• Substance P-like immunoreactive substance in bronchoalveolar lavage fluids from patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

  1996cites this paper
• Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.

  1996cites this paper
• Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.

  1996cites this paper
• Down‐regulation of Cytokine Expression in Murine Lymphocytes by PACAP and VIP

  1996cites this paper
• Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.

  1996cites this paper
• Autocrine loop through cholecystokinin-B/gastrin receptors involved in growth of human leukemia cells.

  1996cites this paper
• Modulation of the Proliferative Response of Murine Peyer's Patch Lymphocytes by Different Peptides: CCK-8, CGRP, CCK-PZ and VIP. Preliminary Results

  1995cites this paper
• Effects of substance P on the growth processes in rat thyroid lobes in vitro.

  1995cites this paper
• Neuropeptide Regulation of Cytokine Expression: Effects of VIP and Ro 25–1553

  1995cites this paper
• Inhibition of murine peritoneal macrophage functions by sulfated cholecystokinin octapeptide.

  1995cites this paper
• The primary afferent nociceptor and neuropeptide gene expression : importance in experimental arthritis

  1994cites this paper
• Physiological Role of Placental Proteases: Interaction Between Pregnancy-Induced Bioactive Peptides and Proteases

  1994cites this paper
• Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex.

  1994cites this paper